Skip to main content
OpenTrials
Completed

NCT Number: NCT03061123

Patient Perceptions and Physician Assessment of Benefits and Risks of Oral Anticoagulation Due to Non-valvular AF

The risk of stroke is markedly elevated in patients with atrial fibrillation (AF). Oral anticoagulation (OAC) is indicated in individuals with moderate and high risk of stroke to the disadvantage of an increased burden from bleeding. Adequate knowledge of this disorder and understanding the benefits and hazards of antithrombotic treatment are essential to incorporate patient´s values and preferences in these decisions. This will further improve acceptance of recommended therapy and augment compliance with OAC.

The objective of this investigation is to compare patient´s perceptions and physician´s assessments of benefits and risks of OAC.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Atrial Fibrillation Arrhythmias, Cardiac Cardiovascular Diseases Health Literacy Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

LKH Feldbach, Feldbach, Austria

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed and ECG-documented non-valvular atrial fibrillation
  • New indication for oral anticoagulation (OAC)
  • Ability of informed consent

Exclusion criteria

  • Existing OAC therapy
  • Valvular heart disease
  • History of valve surgery

Treatment and study plan

Questionnaire

Other

Primary outcomes

  1. Comparison of subjective stroke risk perception with CHA2DS2-VASc score

    Time frame: Baseline

  2. Comparison of subjective bleeding risk perception with HAS-BLED score

    Time frame: Baseline

Secondary outcomes

  1. Relationship between accurate perception of stroke and bleeding risks and baseline parameters (highest completed level of education, subjective level of information)

    Time frame: Baseline

Sponsors and collaborators

Lead sponsor

Medical University of Graz

Other

Registry information

Official study title

Patient Perceptions and Physician Assessment of Benefits and Risks of Oral Anticoagulation Due to Non-valvular Atrial Fibrillation

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Feb 23, 2017
Registry last updated
Sep 15, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.